Presentations

2016

Paulden, M., O’Mahony, J., and McCabe, C. The determinants of change in the cost-effectiveness threshold. 2016 CADTH Symposium. Ottawa, ON. 10-12 April 2016.

Akude, P., Mahjoub, R., Paulden, M., and McCabe, C. A framework for cost-effectiveness analysis of Personalized Medicine co-dependent technologies. 2016 CADTH Symposium. Ottawa, ON. 10-12 April 2016.

Paulden, M., O’Mahony, J., and McCabe, C. Decision rules for value-based reimbursement: Moving on from ‘net health benefit.’ 2016 CADTH Symposium. Ottawa, ON. 10-12 April 2016. (poster)

2015

Mahjoub, R. Cost-Effectiveness of Genetic Diagnostic and Treatment Co-Dependent Technologies Under Uncertainty. University of Leeds. Leeds, UK. 21 October 2015. 

Caulfield, T. Why All the Bunk? Public Trust, Pseudoscience and the Battle for Your Beliefs. La Ka Shing Knowledge Institute. Toronto, ON. 30 September 2015. 

Caulfield, T. Celebrity Spin: What’s Driving (and How to Deal With) Health Myths & Pseudoscience? College of Physicians and Surgeons of British Columbia. Vancouver, BC. 25 September 2015. 

Caulfield, T. Technology Push: Commercialization Pressure, Science Hype and Public Expectation, Assessing the Social and Ethical, Environmental and Economic Impacts of Emerging Technologies. Monash University. Melbourne, Australia. 9 September 2015. 

Caulfield, T. Pressure, Commercialization and the Issue of Science Hype. University of Helsinki. Helsinki, Finland. 17 August 2015.

Mahjoub, R. Cost-effectiveness of genetic diagnostic and treatment co-dependent technologies under uncertainty. INFORMS Healthcare. Nashville, TN. 31 July 2015.

Van Zyl, C. Canadian Patent Litigation of Psychiatric Pharmaceuticals. International Congress of Law and Mental Health. Vienna, Austria. 23 July 2015. 

Hey, S. and Barsanti-Innes, B. Multi-Modal Discordance and the Ontology of Biomarker Research. International Society of History, Philosophy and Social Studies of Biology. Montreal, QC. 6 July 2015.  

Caulfield, T. The Clinic of the Future: Revolution Free (I Hope So!) Oxford University. Oxford, UK. 23-25 June 2015.

Caulfield, T. Bioethics, Technology and the Body: Who Owns What?” le corps en question(s)2 the body in question(s). University of Alberta Museums. Edmonton, AB. 19 June 2015.

Gold, R. Changing the landscape of gene patents: social science at work. Genome Alberta Mini Symposium on ‘Genomics and Personalized Health: health policy and barriers to adoption’. Edmonton, AB. 18 June 2015.

Mahjoub, R. Cost-effectiveness of genetic diagnostic and treatment co-dependent technologies under uncertainty. CORS/INFORMS. Montreal, QC. 17 June 2015.

Caulfield, T. When Celebrities and Culture Clash! Edmonton Community Foundation. Edmonton, AB. 16 June 2015.

Caulfield, T. Biomedicine, Commercialization and the Challenge of Science Hype. University of Heidelberg. Heidelberg, Germany. 11 June 2015.

Bubela, T. Intellectual Property Law and Technology Commercialization. Case studies used to teach one week intensive course for U of A MBA students. 8-12 June 2015.

Toews, M. Implications of Commercialization Pressure in Genomic Research. Research Ethics Group, Alberta Innovates Health Solutions. Edmonton, AB. 5 June 2015. 

Caulfield, T. Finding Truth in a sea of myth and misinformation. Dieticians of Canada National Conference. Quebec City, QC. 4-6 June 2015.

Bubela, T. Mining Data Mountain: Data-sharing principles and practices [invited speaker]. Community Meeting: Analysis, Management and Sharing of Antigen Receptor Repertoire Sequence Data. 31 May 2015.

Caulfield, T. Celebrities and Science Spin. Canadian Association of Emergency Physicians Annual Conference. Edmonton, AB. 30 May – 3 June 2015.

Caulfield, T. Nutrigenetics Translation: From Genetic Variation to Dietary Intervention. Canadian Nutrition Society Annual Conference. Winnipeg, MB. 28-30 May 2015.

Caulfield, T. The Forces that Twist Health Science (and How to Get to the Truth). 2015 Stirling Lecture, Workers Compensation Board. Edmonton, AB. 26-27 May 2015. 

Mahjoub, R. Evaluation of a pharmaceutical risk-sharing agreement when patients are screened for the probability of success. ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015.

Paulden, M. Should decision makers embrace ‘non-constant’ discounting? ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015. (Poster.)

Paulden, M. Incorporating social values into cost-effectiveness analysis. ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015. (Two presentations.)

Akude, P. Advancing Methods of HTA: Optimising Monitoring Tests to Meet Value Targets. ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015.

Caulfield, T. The Forces That Twist Science. Fifth International Congress on Bone Conduction Hearing and Related Technologies. Lake Louise, AB. 20-23 May 2015.

Mahjoub, R. A supply chain design and optimization for non-reactor-based production of Tc-99m medical imaging isotope. POMS. Washington, DC. 11 May 2015. (Poster.)

Caulfield, T. Genetic Modifications in Humans: The Scientific Methods, Medical Applications and Ethical Implications. ISSCR Webinar. 8 May 2015.

Caulfield, T. When Celebrity Culture and Science Clash. Centre for Inquiry. Ottawa, ON. 6 May 2015.

Caulfield, T. Defining Trust in Science and the Factors that Erode It” Does the Public Trust Science? National Academy of Sciences. Washington, DC. 5 May 2015. 

Caulfield, T. Keynote: Is Gwyneth Really Wrong (and Why It Matters)? Celebrities, Science and Our Health. CAREB-ACCER 2015 National Conference and AGM. Vancouver, BC. 1-2 May 2015.

McCabe, C. and Bubela, T. Translational Research for Reimbursement: The Value Engineered Translation Framework. BioCanRx Board Meeting. Ottawa, ON. 1 May 2015.

Caulfield, T. Debunking Health Myths. University of Alberta Alumini, President’s Farewell Reception. Hong Kong. 28 April 2015.

Bubela, T. The Global Landscape of Cellular Immunotherapy Clinical Trials. Canadian GE3LS and Health Services and Policy Research Conference. Vancouver, BC. 18-21 April 2015.

Bubela, T. Co-organiser and Chair: Session 6 – Innovating molecular diagnostic technologies for the clinic. Canadian GE3LS and Health Services and Policy Research Conference. Vancouver, BC. 21 April 2015.

Bubela, T. Headroom and Value in Biotherapeutics R&D [invited speaker]. Canadian GE3LS and Health Services and Policy Research Conference. Vancouver, BC. 20 April 2015.

Toews, M. ‘Marginally Scientific?’ Genetic Testing of Children and Adolescents for Lifestyle and Health Promotion. Vancouver, BC. 18-21 April 2015. (Poster)

Caulfield, T. Academic research in genomics: Facing the translation and commercialization policy pressure. Canadian GE3LS and Health Services & Policy Research Conference: Integrated Approaches to Challenges in the Genomics Era. Vancouver, BC. 18-21 April 2015.

Caulfield, T. When Celebrity Culture and Science Clash. Centre for Inquiry. Toronto, ON. 15 April 2015. 

Paulden, M. Should decision makers embrace ‘non-constant’ discounting? Saskatoon, SK. 12-14 April 2015. (Podium)

Paulden, M. Transforming the cost-effectiveness threshold into a ‘value threshold’: initial findings from a simulation model. Saskatoon, SK. 12-14 April 2015. (Poster and workshop)

Wallner, K. Investigating the Expected Net Benefit of Sampling: the PRESSURE 2 Trial on the Prevention of New Pressure Ulcers. Saskatoon, SK. 12-14 April 2015. (Poster)

Caulfield, T. The Limits of Personalized Medicine. CIHR Best Brains Exchange: Canada as a Leader in the Development and Deployment of Precision/Personalized Medicine. Ottawa, ON. Mar 2015.

Toews, M. Genetic Research Under Pressure: Implications of the Drive to Commercialize Research Findings. Biological Speaker Series. MacEwan University. Edmonton, AB. Mar 2015.

Caulfield, T. When Celebrity Culture and Science Clash: The Twisting of Research and Health Policy. Baker Institute of Public Policy. Rice University. Houston, TX. Mar 2015.

McCabe, C. Value Engineered Translation. Alberta Health Services Lunch and Learn. Mar 2015.

McCabe, C. Why I Hate MCDA. UBC Centre for Health Services and Policy Research Conference. Vancouver, BC. Mar 2015.

Caulfield, T. When Celebrity Culture and Science Clash: The Distortion of Independent Research. Olivieri Lectureship on Medical Ethics. University of Alberta. Edmonton, AB. Jan 2015.

McCabe, C. What has health economics ever done for the NHS? UK Health Economics Study Group Conference. Leeds, UK. Jan 2015.

2014

Paulden, M. Transforming the cost-effectiveness threshold into a ‘value threshold’: initial findings from a simulation model. NICE and the cost-effectiveness thresholds: Can good intentions compensate for bad practice? University College London. London, UK. Dec 2014.

McCabe, C. The risks of reactive translation: a case study. Regenerative Medicines Translation – a pathway into clinical practice. University of Alberta, UK NICE and Cell Catapult. London, UK. Dec 2014.

McCabe, C; Bubela, T. Translational Research for Reimbursement: The Value Engineered Translation Framework. Regenerative Medicine Translation – a pathway into clinical practice. [invited speakers and workshop co-organizers]. University of Alberta, UK NICE and Cell Catapult. London, UK. Dec 2014.

Bubela, T. Technology Landscaping to Support Value Engineered Translation. Methods to Support Regenerative Medicine Translation. Regenerative Medicines Translation – a pathway into clinical practice. University of Alberta, UK NICE and Cell Catapult. London, UK. Dec 2014.

Bubela, T. Traversing the 3 Rs: Regeneration, Regulation, & Reimbursement. London Regenerative Medicine Network. London, UK. Dec 2014.

Paulden, M. Do Social Values Transform the Value-Based Translational Calculus for Regenerative Medicine? Driving Regenerative Medicine to the Market and Clinic. Toronto, ON. Nov 2014.

McCabe, C; Bubela, T. Addressing Barriers to Clinical Translation of Regenerative Medicine. Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges. Toronto, ON. Nov 2014.

Caulfield, T. Introductory Comments, Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments, and Ethical-Legal Challenges. Toronto, ON. Nov 2014.

Caulfield, T. The Obesity Gene and the Misplaced Search for a Personalized Approach to or Weight Gain Problems. Centre for Law and Biosciences Workshop. Stanford University, CA. Nov 2014.

Paulden, M. The Lambda Complex: Knowing Your Place In The Threshold Matrix (Poster). 36th Annual Meeting of the Society for Medical Decision Making. Miami, FL. Oct 2014.

Caulfield, T. The Cure for Everything: The Forces that Twist – What We Hear About Science and Health. CSACI Annual Scientific Meeting. Ottawa, ON. Oct 2014.

Caulfield, T. Genome Research and Translation: The Hope, Harm and Confusion. Po-Gen Seminar on Genetics and Health Care. University of Ireland. Oct 2014.

Caulfield, T. Is Personalized Medicine Really the Answer? Mapping the Benefits and Limits of Using Genetic Testing to Improve Your Health. Reykjavik, Iceland. Oct 2014.

McCabe, C. Beyond the cookie-cutter: choosing what to pay for in the era of patient centred care. Canadian Health Policy Assembly. Banff, AB. Oct 2014.

Akude, P. Poster Presentation: Advancing Methods of HTA: Optimising monitoring tests to meet value targets. Society for Medical Decision Making (SMDM) Conference. Miami, FL. Oct 2014.

Paulden, M. Do Social Values Transform the Value-Based Translational Calculus for Regenerative Medicine? Commercialization Workshop. University of Alberta and Stem Cell Network. Toronto, ON. Oct 2014.

McCabe, C. Value Engineered Translation: Stem Cell Therapies in Diabetes, VET CASE Study. Commercialization Workshop. University of Alberta and Stem Cell Network. Toronto, ON. Oct 2014. Ottawa, ON. Oct 2014.

McCabe, C. Gearing Clinical Studies for Reimbursement Success. Till and McCullogh: CCRM fringe event. Ottawa, ON. Oct 2014.

McCabe, C. Health Economics and Clinical Translation of Stem Cell Technologies.Till and McCullogh Clinical Trials Reimbursement. Ottawa, ON. Oct 2014.

Akude, P. Advancing Methods of HTA: Optimising Monitoring Tests to Meet Value Targets (poster). SMDM. Miami, Florida. Oct 2014.

McCabe, C. Time to stop paying for lemons: linking payment to results for medical technologies. CADTH 25th Anniversary Lecture. Ottawa, ON. Sept 2014.

Caulfield, T. Twisting the Truth?: An Exploration of the Forces that Distort What we Hear and Believe About What Makes Us Healthy. Basel, Switzerland. Aug 2014.

Zarzecny, Z. Personalized Medicine: Altering the Role of Medical Necessity in Health System Policy. International Political Science Association Conference. Montreal, Qc. Jul 2014.

Bubela, T. Intellectual Property and the Mouse Commons. The Network for Bodies, Organs and Tissues (NBOT) Inaugural Annual Symposium. Faculty of Law, University of Sydney, Sydney, Australia. Jul 2014.

Bubela, T. Cost Effective Therapeutic Development of Regenerative Medicine. Leading or Limping?: Regulation in the Age of Personalised Medicine. University of Tasmania, Australia. Jul 2014.

Caulfield, T. Regulation and Personalized Medicine: Focusing Reform. Leading or Leaping?: Regulation in the Age of Personalized Medicine. University of Tasmania, Australia. Jul 2014.

Caulfield, T. Health Myths and the Forces that Twist. Inaugural Ethics, Law and Society Lecture. University of Adelaide, Australia. Jul 2014.

Zarzecny A. Personalized Medicine: Altering the Role of Medical Necessity in Health System Policy.International Political Science Association Conference. Montreal, Qc. Jul 2014.

Pillay JF, Stafinski T, Menon D. Public input for supporting policy development for pharmacogenomics: A scoping review. Poster presentation at the 2014 Annual Conference of Health Technology Assessment International. Washington DC. Jun 2014.

McCabe, C. Commercialisation for value based market access. Centre for Commercialization of Regenerative Medicine. Toronto, ON. Jun 2014.

Gold ER. PACEOMICS: Personalized, Accessible, Cost-Effective ‘Omics Technologies. Sommet sur les soins de santé personnalisées. Montreal, Qc. Jun 2014.

Kamenova K. Celebrity Medicine and the Media: Newspaper Coverage of Angelina Jolie’s Preventative Mastectomy. Canadian Communication Association Annual Meeting. St Catherines, ON. May 2014.

Caulfield T. Health Myths and Science Hype: Why all the Confusion? Biology and Chemistry Regionals Annual Conference. Edmonton, AB. May 2014.

Caulfield T. From Celebrities to Science Hype: Twisting the Truth About Healthy Living. Wake Forest Journal of Law and Policy Annual Symposium. Winston-Salem, North Carolina. April 2014.

Caulfield T. Who Controls Your Genes, Cells and Tissue? Institute for Values in Policy and Science, Simon Fraser University. Burnaby, BC. Mar 2014.

Caulfield T. Science Hype. Presidential Commission for the Study of Bioethical Issues. Washington DC. Feb 2014.

Caulfield T. Genohype: Implications for Policy and Guideline Development. Primary Care Genomics: Peter Wall Institute For Advanced Studies Workshop, University of British Columbia. Vancouver, BC. Feb 2014.

Caulfield T. The Policy Challenges and Health Limits of Personalized Medicine. Peter Wall Institute for Advanced Studies, University of British Columbia. Vancouver, BC. Feb 2014.

Caulfield T. Biotechnology and the Media. Regenerative Medicine, Institute of Medical Science, University Health Network, Toronto, ON. Feb 2014.

2013

Gold ER. A World of Confusion: Patent Law and the Life Sciences. Canadian Science Policy Conference. Toronto, ON. Nov 2013.

Gold ER. Myriad and Beyond: The fallout of the US Supreme Court decision. Science and Technology Studies Colloquium. Vancouver, BC, Nov 2013.

Bubela T. Collaborative Mechanisms for the Clinical Translation of Stem Cell Therapies in a Global Environment. University of Wisconsin Law School. Madison, WI. Oct 2013.

McCabe C. Personalized Medicine: a Testing Evaluation. CSPS Conference. Vancouver, BC. May 2013.

Bubela T. Commercialization and Translational Challenges for Whole Genome Sequencing. Exploring the unique social/ ethical and health system challenges of low cost whole genome sequencing. CIHR Institute of Genetics, Montreal, Qc. Apr 2013.

Caulfield T. Reexamining the Promise and Perils of Personalized Medicine: Patents and Beyond. Genes & Diagnostics: A Myriad of Issues. Keynote address. Cold Spring Harbor Laboratory, New York, Mar 2013.

Caulfield T. The Genetic ‘Revolution’ and Personalized Healthcare: Why We Shouldn’t Hold Our Breadth. Presentation at McMaster University Health Forum, Hamilton, ON, Jan 2013.